Int J Obes (Lond). 2010 Feb;34(2):217-26. doi: 10.1038/ijo.2009.195. Epub 2009 Oct 13.
Type 2 diabetes is associated with obesity and is increasing at an alarming rate in youth. Although weight loss through lifestyle change is one of the primary treatment recommendations for adults with type 2 diabetes, the efficacy of this approach has not been tested with youth. This paper provides a summary of the reviews and meta-analyses of pediatric weight-loss interventions that informed the design and implementation of an intensive, family-based lifestyle weight management program for adolescents with type 2 diabetes and their families developed for the Treatment Options for type 2 Diabetes in Adolescents and Youth (TODAY) study. A total of 1092 youth have been screened, and 704 families have been randomized for inclusion in this 15-center clinical trial sponsored by the National Institutes of Health. The TODAY study is designed to test three approaches (metformin, metformin plus rosiglitazone and metformin plus an intensive lifestyle intervention) to the treatment of a diverse cohort of youth, 10-17 years of age, within 2 years of their diagnosis. The principal goal of the TODAY Lifestyle Program (TLP) is to decrease baseline weight of youth by 7-10% (or the equivalent for children who are growing in height) through changes in eating and physical activity habits, and to sustain these changes through ongoing treatment contact. The TLP is implemented by interventionists called Personal Activity and Nutrition Leaders (PALs) and delivered to youth with type 2 diabetes, and at least one family support person. The TLP provides a model for taking a comprehensive, continuous care approach to the treatment of severe overweight in youth with comorbid medical conditions such as type 2 diabetes.
2 型糖尿病与肥胖有关,在年轻人中的发病率正以惊人的速度增长。尽管通过生活方式改变来减肥是 2 型糖尿病成人的主要治疗建议之一,但这种方法在年轻人中的疗效尚未得到验证。本文总结了儿科减肥干预措施的综述和荟萃分析,为青少年 2 型糖尿病及其家庭的强化、基于家庭的生活方式体重管理计划的设计和实施提供了信息,该计划是为治疗青少年和青年 2 型糖尿病(TODAY)研究而开发的。共有 1092 名青少年接受了筛查,其中 704 个家庭被随机纳入了这项由美国国立卫生研究院资助的 15 中心临床试验。TODAY 研究旨在测试三种方法(二甲双胍、二甲双胍加罗格列酮和二甲双胍加强化生活方式干预)治疗一个多样化的青少年队列,年龄在 10-17 岁之间,诊断后 2 年内。TODAY 生活方式计划(TLP)的主要目标是通过改变饮食和体育活动习惯,使青少年的基线体重减少 7-10%(或身高增长的相应体重),并通过持续的治疗接触维持这些变化。TLP 由称为个人活动和营养领导者(PALs)的干预者实施,并提供给患有 2 型糖尿病的青少年和至少一名家庭支持人员。TLP 为治疗患有 2 型糖尿病等合并症的青少年严重超重提供了一种综合、持续护理的方法。